1. The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis. Issue 1 (March 2020) Authors: Derfuss, T; Sastre-Garriga, J; Montalban, X; Rodegher, M; Wuerfel, J; Gaetano, L; Tomic, D; Azmon, A; Wolf, C; Kappos, L Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 6:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗